HB 1160 repeals the legal requirement for a medical marijuana oversight committee in South Dakota. The bill ends a committee that was mandated to meet twice yearly to evaluate the medical cannabis program, including patient access, dispensary operations, testing facilities, and regulatory safeguards. This change removes the committee's structure and duties, which included making recommendations to the legislature about the program's effectiveness and regulations. The repeal applies to the medical cannabis program established under existing law.
HB 1068 allows South Dakota pharmacists to dispense ivermectin and hydroxychloroquine to adults 18+ based on written protocols created by physicians. These protocols must include risk assessments, drug information (indications, usage, side effects), and instructions for handling adverse events. The law shields physicians and pharmacists from liability for good-faith compliance, except in cases of gross negligence or willful misconduct. It directly affects healthcare providers who dispense these drugs and patients receiving them under this new process.
HB 1112 modifies South Dakota's definition of "electronic smoking device" to explicitly include any device containing or delivering nicotine (or other substances with nicotine) intended for human consumption. This change clarifies that e-cigarettes, vape pens, e-cigars, and similar devices delivering nicotine fall under the definition, regardless of other substances they may contain. The amendment directly affects tobacco businesses selling these products and enforcement of existing laws regulating electronic smoking devices. The bill does not create new restrictions but ensures the definition aligns with how such devices are commonly used and marketed.
HB 1212 repeals a provision that previously shielded women from criminal liability for unlawful abortions. It removes the exception that prevented homicide charges when an abortion caused an unborn child's death, making such cases subject to standard homicide laws (Class B felony). The bill directly affects women seeking abortions and medical providers performing them, as it eliminates prior legal protections for abortion-related deaths. Exceptions for lifesaving procedures to preserve the mother's life or spontaneous miscarriages remain unchanged.
HB 1085 requires South Dakota health insurers to cover nonopioid prescription drugs for pain treatment when prescribed by a doctor, without denying coverage in favor of opioids. Insurers cannot impose stricter approval steps (like prior authorization) or higher cost-sharing tiers for nonopioid drugs compared to opioids or narcotics. This directly affects patients seeking pain management and insurers operating in South Dakota, ensuring equal coverage treatment for nonopioid options when clinically appropriate. The law applies to all health insurance policies sold or renewed in the state.
South Dakota's Senate Concurrent Resolution 603 supports the U.S. Department of Agriculture (USDA) in establishing a federal working group of nutrition experts to develop evidence-based national standards for foods and beverages that can be purchased with Supplemental Nutrition Assistance Program (SNAP) benefits. The resolution does not create new law but urges Congress to pass legislation implementing the working group’s recommendations, which would align SNAP purchasing rules with current nutrition science and dietary guidelines. It directly affects the federal SNAP program, which provides food assistance to millions of low-income Americans, including South Dakota residents. The resolution emphasizes that national standards require federal action to ensure consistency, avoid state administrative costs, and prevent future policy reversals. This is a supportive measure for federal policy development, not a direct change to SNAP benefits or eligibility.
HB 1053 requires terminal care facilities (hospitals, inpatient hospice, or residential hospice) to permit terminally ill patients with a medical cannabis card to store and use medical cannabis within the facility. It mandates that patients provide their registry card and a physician's note documenting the need, while prohibiting smoking or vaping on-site. Facilities must establish policies for administration and storage but are not required to procure or administer cannabis. This applies only to patients with a terminal condition (life expectancy under one year) and excludes emergency departments. The bill does not override federal enforcement actions against facilities that comply with federal law.